Zobrazeno 1 - 9
of 9
pro vyhledávání: '"van der Horst, Edward Htun"'
Autor:
van der Horst, Edward Htun, Chinn, Lawrence, Wang, Min, Velilla, Timothy, Tran, Hoang, Madrona, Yarrow, Lam, Andrew, Ji, May, Hoey, Timothy C, Sato, Aaron K
The receptor tyrosine kinase MET is a major component controlling the invasive growth program in embryonic development and in invasive malignancies. The discovery of therapeutic antibodies against MET has been difficult, and antibodies that compete w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9b2c9f7a192e1f9b8bdc79ebc5ea8246
https://europepmc.org/articles/PMC2657888/
https://europepmc.org/articles/PMC2657888/
Autor:
van der Horst, Edward Htun, Frank, Brendon T, Chinn, Lawrence, Coxon, Angela, Li, Shyun, Polesso, Fanny, Slavin, Anthony, Ruefli-Brasse, Astrid, Wesche, Holger
Midkine (MDK) is a heparin-binding growth factor involved in growth, survival, migration, and differentiation of various target cells and dysregulation of MDK signaling is implicated in a variety of inflammatory diseases and cancers. Although MDK has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bbfa6310e3a435064b75216f465f4dda
https://europepmc.org/articles/PMC2288540/
https://europepmc.org/articles/PMC2288540/
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
van der Horst, Edward Htun, Degenhardt, Yan Y., Strelow, Astrid, Slavin, Anthony, Chinn, Lawrence, Orf, Jessica, Minqing Rong, Shyun Li, Lei-Hoon See, Nguyen, Ken Q. C., Hoey, Timothy, Wesche, Holger, Powers, Scott
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America; 11/1/2005, Vol. 102 Issue 44, p15901-15906, 6p
Publikováno v:
International Journal of Cancer; Jul2005, Vol. 115 Issue 4, p519-527, 9p
Publikováno v:
International Journal of Cancer; Feb2005, Vol. 113 Issue 5, p689-698, 10p
Autor:
van der Horst EH; Department of Cancer Biology, OncoMed Pharmaceuticals Inc., 800 Chesapeake Dr., Redwood City, CA 94063, USA. edward.vanderhorst@oncomed.com, Chinn L, Wang M, Velilla T, Tran H, Madrona Y, Lam A, Ji M, Hoey TC, Sato AK
Publikováno v:
Neoplasia (New York, N.Y.) [Neoplasia] 2009 Apr; Vol. 11 (4), pp. 355-64.
Autor:
van der Horst EH; Department of Oncology, Amgen Inc., 1120 Veterans Blvd, South San Francisco, CA 94080, USA., Frank BT, Chinn L, Coxon A, Li S, Polesso F, Slavin A, Ruefli-Brasse A, Wesche H
Publikováno v:
Neoplasia (New York, N.Y.) [Neoplasia] 2008 Apr; Vol. 10 (4), pp. 340-7.
Autor:
van der Horst EH; U3Pharma, Martinsried, Germany., Leupold JH, Schubbert R, Ullrich A, Allgayer H
Publikováno v:
BioTechniques [Biotechniques] 2004 Dec; Vol. 37 (6), pp. 940-2, 944, 946.